bupropion hydrochloride sr

Generic: bupropion hydrochloride

Labeler: slate run pharmaceuticals, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name bupropion hydrochloride sr
Generic Name bupropion hydrochloride
Labeler slate run pharmaceuticals, llc
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

bupropion hydrochloride 100 mg/1

Manufacturer
Slate Run Pharmaceuticals, LLC

Identifiers & Regulatory

Product NDC 70436-058
Product ID 70436-058_1b0de43f-05c2-aed6-e063-6394a90ac5df
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211347
Listing Expiration 2026-12-31
Marketing Start 2020-11-02

Pharmacologic Class

Classes
aminoketone [epc] dopamine uptake inhibitors [moa] increased dopamine activity [pe] increased norepinephrine activity [pe] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70436058
Hyphenated Format 70436-058

Supplemental Identifiers

RxCUI
993503 993518 993536
UNII
ZG7E5POY8O

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bupropion hydrochloride sr (source: ndc)
Generic Name bupropion hydrochloride (source: ndc)
Application Number ANDA211347 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-058-01)
  • 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-058-02)
  • 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-058-05)
source: ndc

Packages (3)

70436-058-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-058-01) 70436-058-02 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-058-02) 70436-058-05 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-058-05)

Ingredients (1)

bupropion hydrochloride (100 mg/1)

Linked Drug Pages (1)

Bupropion Hydrochloride SR ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "1b0de43f-05c2-aed6-e063-6394a90ac5df", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993503", "993518", "993536"], "spl_set_id": ["7c4313fa-bb29-dd50-e053-2991aa0a3005"], "manufacturer_name": ["Slate Run Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-058-01)", "package_ndc": "70436-058-01", "marketing_start_date": "20201102"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-058-02)", "package_ndc": "70436-058-02", "marketing_start_date": "20201102"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-058-05)", "package_ndc": "70436-058-05", "marketing_start_date": "20201102"}], "brand_name": "Bupropion Hydrochloride SR", "product_id": "70436-058_1b0de43f-05c2-aed6-e063-6394a90ac5df", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "70436-058", "generic_name": "bupropion hydrochloride", "labeler_name": "Slate Run Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "SR", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA211347", "marketing_category": "ANDA", "marketing_start_date": "20201102", "listing_expiration_date": "20261231"}